News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Beth Israel Deaconess Medical Center : Proteomic Profiling Shown More Accurate Than Traditional Biomarkers In Identifying Liver Cancer



1/16/2008 8:06:46 AM

As the incidence of liver cancer continues to grow-- fueled in large part, by rising rates of hepatitis C infections -- so too does the need for tests to help diagnose the disease at an earlier stage. A study appearing in the January 15 issue of Clinical Cancer Research demonstrates that a novel mass-spectrometry based form of proteomic profiling is more accurate than traditional biomarkers in distinguishing liver cancer patients from patients with hepatitis C liver cirrhosis, particularly with regard to identifying patients with small, curable tumors. Led by researchers at Beth Israel Deaconess Medical Center (BIDMC), the study could help lead to earlier diagnostic methods -- and subsequent treatments -- for liver cancer.

Read at ScienceDaily


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES